CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Budapest, Hungary and 374 other locations
for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...
Phase 2
Tatabánya, Hungary and 37 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Budapest, Hungary and 506 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Budapest, Hungary and 227 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Budapest, Hungary and 258 other locations
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer...
Phase 3
Budapest, Hungary and 273 other locations
Researchers are looking for new ways to treat types of breast cancer that are both:* High-risk, which means the cancer may ...
Phase 3
Budapest, Hungary and 320 other locations
receptor-low/HER2-negative breast cancer....
Phase 3
Budapest, Hungary and 282 other locations
Clinical trials
Research sites
Resources
Legal